Veterinary Medicines

Rispoval IBR-Marker InactivatumSuspension for injection for cattle

Authorised
  • Infectious Bovine rhinotracheitis virus, strain Difivac gE gene-deleted, Inactivated
Download as PDF

Product identification

Medicine name:
Rispoval IBR-Marker InactivatumSuspension for injection for cattle
Rispoval IBR-Marker Inactivatum, suspension injectable pour bouvins
Active substance:
  • Infectious Bovine rhinotracheitis virus, strain Difivac gE gene-deleted, Inactivated
Target species:
  • Cattle
  • Cattle (for meat production)
  • Cattle (calf)
  • Cattle (heifer)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious Bovine rhinotracheitis virus, strain Difivac gE gene-deleted, Inactivated
    0.01
    titre
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (for meat production)
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • (ID3) 100 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 100 millilitre(s)
  • (ID2) 20 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 20 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 087/96/01/0475
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0021/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 10/02/2022
Download
French (PDF)
Published on: 16/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."